KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Total Liabilities (2016 - 2025)

Merck (MRK) has disclosed Total Liabilities for 17 consecutive years, with $84.3 billion as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 84160.0% to $84.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $84.3 billion through Dec 2025, up 84160.0% year-over-year, with the annual reading at $84.3 billion for FY2025, 84160.0% up from the prior year.
  • Total Liabilities for Q4 2025 was $84.3 billion at Merck, up from $77.7 billion in the prior quarter.
  • The five-year high for Total Liabilities was $84.3 billion in Q4 2025, with the low at $100.0 million in Q4 2024.
  • Average Total Liabilities over 5 years is $34.6 billion, with a median of $29.1 billion recorded in 2021.
  • The sharpest move saw Total Liabilities tumbled 99.6% in 2023, then surged 84160.0% in 2025.
  • Over 5 years, Total Liabilities stood at $400.0 million in 2021, then surged by 50.0% to $600.0 million in 2022, then plummeted by 58.33% to $250.0 million in 2023, then crashed by 60.0% to $100.0 million in 2024, then soared by 84160.0% to $84.3 billion in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $84.3 billion, $77.7 billion, and $68.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.